Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/06/2003WO2003018631A2 Nogo receptor homologues and their use
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018629A1 Cage antigen
03/06/2003WO2003018628A1 Gene controlling flowering time and method for controlling flowering time in plants using the gene
03/06/2003WO2003018627A1 Gene controlling life span of leaves in plants and method for controlling life span of plants using the gene
03/06/2003WO2003018626A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003WO2003018625A2 Allelic variants of herv-k18 provirus and their use in analysis
03/06/2003WO2003018624A1 Vectors, constructs, and transgenic plants for hpv-11 and hpv-16 l1 capsid protein
03/06/2003WO2003018623A2 Papillomavirus proteins and pharmaceutical compositions
03/06/2003WO2003018622A1 Pseudovirions comprising virus capsids, histones and nucleic acids as therapeutic agents
03/06/2003WO2003018621A2 Genes
03/06/2003WO2003018620A2 Serine protease inhibitor and processes for the preparation thereof
03/06/2003WO2003018619A2 Antimicrobial and anti-inflammatory peptides
03/06/2003WO2003018617A1 Method of purifying human mannose binding lectin, human mannose binding lectin compositions and medicinal use of human mannose binding lectin
03/06/2003WO2003018616A1 A method of sequestering and/or purifying a polypeptide
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018610A2 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
03/06/2003WO2003018606A2 Casein derived peptides and uses thereof in therapy
03/06/2003WO2003018595A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003WO2003018523A1 Process for producing optically active halopropanediol derivative
03/06/2003WO2003018516A2 Glucagon-like peptide-1 analogs
03/06/2003WO2003018066A2 A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
03/06/2003WO2003018065A1 Anti-cancer agents comprising disintegrin genes and the treating methods
03/06/2003WO2003018055A1 Vaccine using papilloma virus e proteins delivered by viral vector
03/06/2003WO2003018053A1 Vaccine against mycobacterial-induced diseases
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018050A1 Gamma three protease
03/06/2003WO2003018048A1 Use of hla class 1 soluble molecules to inhibit angiogenesis
03/06/2003WO2003018046A1 Crystals of luxp and complexes thereof
03/06/2003WO2003018045A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003018037A2 Regulation method of cell growth
03/06/2003WO2003017944A2 Gpi-anchored cytokines
03/06/2003WO2003017943A2 Therapeutic compositions and methods for treating viral infection
03/06/2003WO2003017937A2 Physalia fluorescent proteins
03/06/2003WO2003017934A2 Folded monomers of the hiv-1 protease and methods of their use
03/06/2003WO2003017918A2 A method of inducing the formation of neurofibrillary tangles in transgenic animals
03/06/2003WO2003017769A1 Antimicrobial agent
03/06/2003WO2003017756A1 Rat highly sensitive to carcinogen
03/06/2003WO2003017751A2 Combinations of genes for producing seed plants exhibiting modulated reproductive development
03/06/2003WO2003000729A3 Secreted polypeptide and their use in the treatment of bone disorders
03/06/2003WO2002101021A3 Purification of human serum albumin
03/06/2003WO2002095036A8 A novel intein and uses thereof
03/06/2003WO2002095026A8 Method of proliferating terminal differentiated cells and recombinant vector therefor
03/06/2003WO2002092122A3 Use of osteopontin for the treatment and/or prevention of neurologic diseases
03/06/2003WO2002088327A9 Methods for viral oncoapoptosis in cancer therapy
03/06/2003WO2002088319A3 Mini-adenoviral vector and methods of using same
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002086061A3 Vesicle-associated proteins
03/06/2003WO2002083068A8 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
03/06/2003WO2002081709A3 Modified hpv e6 and e7 genes and proteins useful for vaccination
03/06/2003WO2002081683A3 Protein analysis by means of immobilized arrays of antigens or antibodies
03/06/2003WO2002079446A3 Transgenic mice containing gpr31 gene disruptions
03/06/2003WO2002079399A8 Regulatable growth of filamentous fungi
03/06/2003WO2002078437A3 Novel pesticidal toxins
03/06/2003WO2002078427A3 Specification of meiocyte and tapetal cell layers in plants
03/06/2003WO2002077276A3 Novel signalling polypeptide
03/06/2003WO2002074928A3 Fusion peptides isolatable by phase transition
03/06/2003WO2002074908A3 Methods and reagents for regulating apoptosis
03/06/2003WO2002074249A3 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002072767A3 Mammalian neuralized family transcriptional regulators and uses therefor
03/06/2003WO2002072761A3 Polypeptides interactive with bcl-x¿l?
03/06/2003WO2002070651A3 Viral reporter particles
03/06/2003WO2002067868A3 Methods for the treatment of metabolic disorders, including obesity and diabetes
03/06/2003WO2002066511A3 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
03/06/2003WO2002065134A3 Modulators of p53-p300 interactions and screening methods therefor
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002064092A3 Method for evaluating therapeutic efficacy
03/06/2003WO2002062959A3 Hepatitis b virus treatment
03/06/2003WO2002062845A3 Adhesion molecules
03/06/2003WO2002060929A3 Polymer conjugates of neublastin and methods of using same
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002059264A3 Specific human antibodies for selective cancer therapy
03/06/2003WO2002057293A3 Modified zinc finger binding proteins
03/06/2003WO2002056837A3 Inhibition of protein-phosphatases for the treatment of heart failure
03/06/2003WO2002056024A3 Detection methods
03/06/2003WO2002052013A3 The flu gene: a tool for the identification of genes involved in stress responses and apoptosis and a target for herbicides specific for angiosperms
03/06/2003WO2002051994A8 Polypeptides
03/06/2003WO2002050273A3 A transmembrane protein as a downstream target of neurotrophin and ephrin receptor tyrosine kinases, dna encoding same monoclonal antibodies thereto
03/06/2003WO2002044378A3 Wnt signalling assay, methods and uses thereof
03/06/2003WO2002042464A3 Human v2 vomeronasal receptor
03/06/2003WO2002034917A3 Secreted alpha-helical cytokine-like protein zlmda24
03/06/2003WO2002033083A3 Methods of using a human il-17-related polypeptide to treat disease
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002031147A3 Human transporter proteins and polynucleotides encoding the same
03/06/2003WO2002030982A3 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use
03/06/2003WO2002022801A3 Mammalian receptor genes and uses
03/06/2003WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/06/2003WO2002022080A9 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
03/06/2003WO2002020765A3 38646, a guanine nucleotide exchange factor and uses therefor
03/06/2003WO2002020748A2 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/06/2003WO2002016430A3 Peptide with effects on cerebral health
03/06/2003WO2002016421A3 Altered ospa of borrelia burgdorferi
03/06/2003WO2002015701A3 Bacillus thuringiensis crystal protein hybrids
03/06/2003WO2002014500A3 Human genes and gene expression products
03/06/2003WO2002014498A3 Human voltage-gated sodium channel proteins (scn1a) and polynucleotides encoding the same
03/06/2003WO2002014492A3 Fatty liver disease resistant bovines
1 ... 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 ... 2916